Please donate here to support this vital work.
Subscribe here to our free email list

Mind-Altering Drugs Media Articles
Excerpts of Key Mind-Altering Drugs Media Articles in Major Media


Below are key excerpts of highly revealing mind-altering drugs articles reported in the major media. Links are provided to the full articles on major media websites. If any link fails to function, read this webpage. These mind-altering drugs articles are listed by article date. You can also explore the articles listed by order of importance or by date posted. By choosing to educate ourselves on these important issues and to spread the word, we can and will build a brighter future.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.


Netflix documentary 'Fantastic Fungi' explores the many magical properties of mushrooms
2021-08-16, San Francisco Chronicle (San Francisco's leading newspaper)
https://www.sfgate.com/streaming/article/Netflix-documentary-Fantastic-Fungi-...

Fungi have been around for billions of years, setting the stage for humanity by supporting, carrying and converting life. But for complex political reasons, these organisms are still shrouded in mystery. One man, however, is determined to lift the veil on the magical world of mushrooms. Enter Stamets, a bespectacled author and researcher whose mission to decode nature's hidden language and explore "altered states of consciousness" is chronicled in the documentary "Fantastic Fungi," which was recently made available to stream on Netflix. While the film aims to destigmatize hallucinogenic mushrooms, it also demonstrates why we should legitimize the studies of all mushrooms. Contemporary experts in neurology, psychiatry and biology in the film show that fungal genomes can solve a host of mental, physical and environmental problems. From healing bacterial infections to cleaning petroleum spills, fungi possess unique, almost godlike properties that are otherwise unseen in nature. For instance, lion's mane, an edible white mushroom that tastes like lobster, stimulates nerves in order to grow, suggesting that it could potentially cure degenerative diseases like Alzheimer's. Ultimately, when Stamets discusses altered states of consciousness, it's ... about accepting a different state of being. For some people – especially those who live in pain – the film posits that mushrooms can be the answer they've been looking for.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Psychedelic trips could soon be part of therapy – here's what those sessions will look like
2021-07-24, CNBC News
https://www.cnbc.com/2021/07/24/how-psychedelic-assisted-therapy-with-mdma-an...

Psychedelic drugs are substances that alter perception and mood and affect a number of cognitive processes. The classic psychedelics include MDMA aka "ecstasy" or "molly," LSD, psilocybin or "mushrooms," ayahuasca and ibogaine. Used in conjunction with therapists, research has shown that psychedelics can help treat historically difficult-to-treat conditions by essentially "reshaping" the way "parts of the brain talk to each other," says Jennifer Mitchell, a neuroscientist. "Psychedelics allow for processing in a way that enables subjects to let go of things that had previously plagued them," she says. As Mitchell explains it, when people are young, their brains go through critical periods of learning and development that then become closed off as they age. Researchers believe that psychedelics "open those closed critical periods for just a tiny window of time," she says. "When that critical period is open again, you want to make the most of it, and make that potential change as positive as possible," she says. With psilocybin, for instance, it is believed the drug boosts connectivity in the brain and increases "neuroplastic states," which are the brain's ability to reorganize and adapt, says Dr. Stephen Ross ... who has been conducting clinical trials on psilocybin-assisted therapy for the past 16 years. MDMA-assisted therapy could be approved by the FDA for medical use as early as 2023, while other psychedelics, notably psilocybin, are waiting in the wings for their turn to be evaluated for medical purposes.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


How Should We Do Drugs Now?
2021-07-09, New York Times
https://www.nytimes.com/2021/07/09/opinion/sunday/drug-legalization-mdma-psil...

In the past two years, a new drug policy reform movement called Decriminalize Nature has persuaded local governments in a half dozen municipalities, including Washington, D.C., to decriminalize "plant medicines" such as psilocybin, ayahuasca, iboga and the cactuses that produce mescaline. Last month, the California State Senate passed a bill that would make legal the personal possession, use and "social sharing" of psychedelics, including LSD and MDMA, a.k.a. Ecstasy or Molly. Political opposition to all these measures has been notably thin. Neither party, it seems, has the stomach for persisting in a war that has achieved so little while doing so much damage, especially to communities of color and our civil liberties. But while we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively? In the case of psychedelics, decriminalizing these powerful compounds is only the first step in a process of figuring out how best to safely weave their use into our society. The main model we have for resocializing a formerly illicit drug is the legalization of cannabis, now the new normal in 18 states. The use of psychedelics by Indigenous peoples ... suggests a model we would do well to keep in mind as we figure out how best to handle these substances.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind altering drugs from reliable major media sources.


MDMA could help trauma survivors face painful memories
2021-05-13, BBC News
https://www.bbc.com/news/health-56997013

MDMA - most commonly known as a party drug - could be more effective than therapy alone at treating post-traumatic stress disorder (PTSD). The results of a keenly-awaited trial suggest two-thirds of people no longer qualified for a PTSD diagnosis after treatment. The study represents a significant step towards approval of the drug in the US. PTSD can be the result of a very distressing or frightening event, or longer-term series of experiences. That might include accidents, abuse, rape, combat or illness. And it can be very difficult to treat. This trial, run by US charity the Multidisciplinary Association for Psychedelic Studies (Maps), found 88% of people had a "meaningful reduction in symptoms" and 67% no longer qualified for a PTSD diagnosis at all after 18 weeks and three sessions of MDMA-assisted therapy. Talking therapy alone led to a significant improvement in 60%, and remission in 32% of people. The participants in the study, which was published in the journal Nature, had suffered from PTSD for an average of 14 years. MDMA appears to work in part by calming the amygdala. In people with PTSD and anxiety disorders, this part of the brain can overreact, sounding the alarm over seemingly small events. When we are babies, and again during adolescence, we experience periods where our brains are very pliable. The scientists involved in the study speculate that psychedelics and similar-acting drugs like MDMA might allow a "reopening" of this critical window of brain development.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.
2021-05-09, New York Times
https://www.nytimes.com/2021/05/09/health/psychedelics-mdma-psilocybin-molly-...

It's been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds. Dr. Doblin's quest to win mainstream acceptance of psychedelics took a significant leap forward ... when the journal Nature Medicine published the results of his lab's study on MDMA, the club drug popularly known as Ecstasy and Molly. The study, the first Phase 3 clinical trial conducted with psychedelic-assisted therapy, found that MDMA paired with counseling brought marked relief to patients with severe post-traumatic stress disorder. The results, coming weeks after a New England Journal of Medicine study that highlighted the benefits of treating depression with psilocybin, the psychoactive ingredient in magic mushrooms, have excited scientists, psychotherapists and entrepreneurs. They say it is only a matter of time before the Food and Drug Administration grants approval for psychoactive compounds to be used therapeutically – for MDMA as soon as 2023, followed by psilocybin a year or two later. Last year, Oregon became the first state to legalize the therapeutic use of psilocybin. Denver, Oakland, Calif., and Washington, D.C., have decriminalized the drug, and several states, including California, are mulling similar legislation. Though the drugs remain illegal under federal law, the Justice Department has so far taken a hands-off approach to enforcement.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


A Psychedelic Drug Passes a Big Test for PTSD Treatment
2021-05-03, New York Times
https://www.nytimes.com/2021/05/03/health/mdma-approval.html

In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy. Of the 90 people who took part in the new study, which is expected to be published later this month in Nature Medicine, those who received MDMA during therapy experienced a significantly greater reduction in the severity of their symptoms compared with those who received therapy and an inactive placebo. Two months after treatment, 67 percent of participants in the MDMA group no longer qualified for a diagnosis of PTSD, compared with 32 percent in the placebo group. MDMA produced no serious adverse side effects. Some participants temporarily experienced mild symptoms like nausea and loss of appetite. Unlike traditional pharmaceuticals, MDMA does not act as a band-aid that tries to blunt symptoms of PTSD. Instead, in people with PTSD, MDMA combined with therapy seems to allow the brain to process painful memories and heal itself. Scott Ostrom, who participated in the study, had suffered from PTSD since returning home from his second deployment in Iraq in 2007. For more than a decade, he experienced debilitating nightmares. Mr. Ostrom's days were punctuated by panic attacks, and he dropped out of college. Therapy and medication did not help. But after participating in the trial, he no longer has nightmares. "Literally, I'm a different person," he said.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Psychedelics for medical purposes: time to change your mind?
2021-03-21, The BMJ (Formerly British Medical Journal)
https://blogs.bmj.com/bmj/2021/03/21/psychedelics-for-medical-purposes-time-t...

There is clearly a psychedelic renaissance underway. These agents are now debated at medical conferences smirk-free, and my investment-obsessed friends predict a financial "'shroom-boom". During the 2020 US election ... Measure 109 asked voters in Oregon whether magic mushrooms should be allowed for medical purposes, and Initiative 81 asked Washingtonians about decriminalizing psychedelic plants and fungi. Research is also underway in institutions from Johns Hopkins to Imperial College London. Recently, Health Canada quietly ... allowed four terminally ill patients to take psilocybin under medical supervision. I have also been asked by several patients, at end-of-life, to prescribe a gram of mushrooms or a tablet of lysergic acid diethylamine (which my pharmacy cannot furnish), rather than a "bucket of fentanyl" (which the pharmacy readily can). The Default Mode Network (DMN) ... refers to interconnected brain regions that help us believe we are a distinct self, separate from others and the natural world. This drives self-reliance, but can make us feel isolated. Moreover, as it "matures," we respond in more habitual, predictable, rigid ways. The theory is that DMN overactivity leads to excessive introspection, hypercriticism, obsession, depression, and anxiety. Psychedelics might decrease the tyranny of the DMN, thereby allowing unfamiliar parts of the brain to go on a play-date. We should not throw out the scientific method, but psychedelics could increase the colors in our crayon set.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


Can Magic Mushrooms Heal Us?
2021-03-18, New York Times
https://www.nytimes.com/2021/03/18/opinion/oregon-psychedelic-therapy.html

Gov. Kate Brown of Oregon announced the members of the state's newly formed Psilocybin Advisory Board this week. Oregon is about to become the first state in the country to try to build a support infrastructure through which psychedelic mushrooms can be woven into everyday life. This framework is different from what we've seen before: not legalization, not medicalization, but therapeutic use, in licensed facilities, under the guidance of professionals trained to guide psychedelic experiences. The ... pressing case for psilocybin comes from research out of Johns Hopkins, U.C.L.A., N.Y.U. and elsewhere that has shown it to be a potentially effective treatment for major depression, end-of-life anxiety and drug addiction. "One of the things I've come to is that addiction medicine in 2021 is in desperate need of transformative technologies," Todd Korthuis, a ... member of Oregon's Psilocybin Advisory Board, told me. Studies ... are "showing dramatic change in people's lives – that's what we need for cocaine use disorder, methamphetamine use disorder, even alcohol and tobacco." A recent study on major depressive disorder, published in JAMA Psychiatry, found more than half of the subjects in remission four weeks later, after just two treatments alongside psychotherapy. A study on tobacco addiction, out of Johns Hopkins, found two-thirds of the subjects who received psilocybin in combination with cognitive behavioral therapy abstinent a year later.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind-altering drugs from reliable major media sources.


'The ketamine blew my mind': can psychedelics cure addiction and depression?
2021-03-13, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/lifeandstyle/2021/mar/13/it-blew-my-mind-can-psyc...

In the summer of 1981, when he was 13, Grant crashed a trail motorbike. Grant hadn't given this childhood memory much thought in the intervening years, but one hot August day ... he suddenly understood it as a clue to his dangerously unhealthy relationship with alcohol. The day before, a team of specialists at the Royal Devon and Exeter hospital had given him an intravenous infusion of ketamine, a dissociative hallucinogen, in common use as an anaesthetic since the 1970s, and more recently one of a group of psychedelic drugs being hailed as a silver bullet in the fight to save our ailing mental health. To date, more than 100 patients with conditions as diverse as depression, PTSD and addiction have been treated in research settings across the UK, using a radical new intervention that combines psychedelic drugs with talking therapy. What was once a fringe research interest has become the foundation of a new kind of healthcare, one that, for the first time in modern psychiatric history, purports to not only treat but actually cure mental ill health. Under its influence, Grant had an out-of-body experience he struggles to put into words. "It was like I was sinking deeper and deeper into myself," he says. "Then I became white… and I left my body. I was up on the ceiling, looking at myself, but I was just this white entity. I felt very serene and humbled; I finally understood my place in the universe, just a white speck of light, I wasn't the centre of everything and that was fine."

Note: For more along these lines, see concise summaries of deeply revealing news articles on the healing potentials of mind altering drugs from reliable major media sources.


Job diary: I'm an LA doctor who runs a ketamine-infusion therapy program to help people overcome depression, anxiety, and trauma
2020-11-10, MSN News
https://www.msn.com/en-us/health/medical/job-diary-im-an-la-doctor-who-runs-a...

While I was in anesthesia residency at the University of Southern California Hospital's Department of Anesthesiology from 2006 to 2009, I learned how to put people under for surgery using an anesthetic called ketamine. Afterwards, as I began work as an anesthesiologist at a hospital, I began hearing interesting things about the anesthetic. Researchers had begun testing it as a treatment for mental health conditions like anxiety, depression, and PTSD – and with encouraging results. It also has psychedelic properties, so people can gain insight into their lives and even have mystical experiences on it. One study found that it reduced symptoms of depression and anxiety in patients with severe depression, both immediately after it was administered and as well as a month down the line. Another found that it even provided relief from chronic pain that lasted for up to two weeks after treatment. In 2014, inspired by findings like these and conversations with psychiatrists who were beginning to incorporate ketamine into their practices, I founded the Ketamine Healing Clinic of Los Angeles. Over time, I've seen people undergo big changes in their lives because of their work with ketamine, including a few who left abusive relationships, grew their businesses, or pursued totally new ventures. Overall ... people typically come out of their infusions with a newfound will to live and increased clarity about their future. Some patients who came in with suicidal thoughts no longer have them at all.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


Oregon becomes first state to legalize magic mushrooms as more states ease drug laws in 'psychedelic renaissance'
2020-11-04, CNBC News
https://www.cnbc.com/2020/11/04/oregon-becomes-first-state-to-legalize-magic-...

Oregon on Wednesday became the first state to legalize the active ingredient in so-called magic mushrooms on an election night that saw more states ease restrictions on recreational drugs across the country. Oregon's Measure 109 will give legal access to psilocybin, the main active ingredient in "magic mushrooms," for mental health treatment in supervised settings. While some cities have moved to legalize and regulate access to the drug, Oregon will become the first state in the country to legalize it on a statewide basis. Supporters of the measure point to the medical benefits of the drug, which has been shown in some studies to benefit trauma survivors. Through Measure 110, which has captured more than 58% of the vote so far, Oregon would also decriminalize the possession of small amounts of some hard drugs, including heroin and LSD. Instead of criminal prosecution, people in possession would face a $100 fine, which can be waived if the person agrees to pursue treatment, according to the measure. Ronan Levy, the cofounder of Field Trip Health, a Toronto-based company that provides psychedelic-enhanced psychotherapy, said the ballot wins are "fantastic news" for what he called the psychedelic renaissance. Research is mounting that indicates the benefits of using psychedelic drugs to enhance therapy, Levy said, adding that ... the drug alone isn't necessarily helpful; it needs to be taken under supervision of trained personnel.

Note: Recent studies suggest psilocybin can be used to treat addiction and anxiety. For more along these lines, see concise summaries of deeply revealing news articles on the healing potential of mind-altering drugs from reliable major media sources.


Silicon Valley and Wall Street Elites Pour Money Into Psychedelic Research
2020-08-20, Wall Street Journal
https://www.wsj.com/articles/silicon-valley-and-wall-street-elites-pour-money...

A group of Silicon Valley and Wall Street executives has raised $30 million to speed the development of a closely watched psychedelic-drug therapy. The Multidisciplinary Association for Psychedelic Studies, a nonprofit advocating for psychedelic research since the 1980s, is conducting its last phase of clinical trials to research the efficacy of using MDMA-assisted psychotherapy for post-traumatic stress disorder. PTSD afflicts about eight million adults a year. MDMA is more commonly known as the main component of Ecstasy. Armed with the new funding, MAPS is aiming to finish the trials and seek approval from the Food and Drug Administration to commercialize the MDMA-assisted psychotherapy as soon as 2022. In 2017, the FDA designated MDMA as a breakthrough therapy for PTSD, meaning it would expedite review of the drug. MAPS said a recent interim analysis of its Phase 3 clinical trials ... showed a very high likelihood the therapy will be effective for treating PTSD. In phase 2 clinical trials, individuals with post-traumatic stress disorder received psychotherapy, some with the psychedelic drug MDMA. More of those who received the drug no longer received a PTSD diagnosis in the months after treatment, compared with those who received a placebo. Business leaders said their donations came from a personal connection to mental-health conditions. Among them is billionaire Bob Parsons, founder of GoDaddy and ... a Marine Corps Vietnam War veteran, who said he has continued to battle PTSD.

Note: To read the entire article free of charge, see this webpage. Note that as big Pharma won't make big profits from these therapies, they are not funding any of the major studies, while the nonprofit MAPS has stepped in to make this happen. And not mentioned in this article is that the results of these studies has been dramatic, with over 2/3 of patients showing no signs of PTSD a year after treatment. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psychedelic Drugs Can Improve Quality Of Life - And Death - For Older Adults
2020-05-06, Forbes
https://www.forbes.com/sites/abbierosner/2020/05/06/psychedelic-drugs-can-imp...

Older Americans suffer disproportionately from chronic pain and its attendant ailments, anxiety, depression and insomnia. In the search for relief, they consume more pharmaceutical drugs than perhaps any comparable cohort on this planet. Psychedelic therapies to treat mental health conditions offer a radical departure from current pharmaceutical models. The psychedelic therapy modalities currently under investigation combine a limited number of treatment sessions with a psychedelic substance, sandwiched between intensive pre- and post-treatment therapy sessions. The ideal, and realistic, outcome from this course of treatment is not mere symptom control, but durable remission. Indeed, these studies are finding that, in clinically significant numbers, recipients of a single course of psychedelic therapy report the experience to be life-changing, and enduring over time. The positive preliminary outcomes of clinical studies by MAPS using MDMA to treat PTSD, and Compass Pathways for psilocybin therapy for treatment-resistant depression, have convinced the FDA to grant them Breakthrough Therapy Designation. In the 1960s researchers were interested in seeing if psychedelic drug treatment could alleviate existential distress in terminal cancer patients. This line of research was picked up 35 years later by Dr. Charles Grob, whose 2011 pilot study of psilocybin treatment for terminal cancer patients found significant enduring reductions in anxiety and improvement in mood at a six-month follow up.

Note: Read more on the healing potentials of mind-altering drugs. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.


After learning Whitey Bulger was unwitting subject of CIA experiment, juror regrets murder conviction
2020-02-18, Los Angeles Times
https://www.latimes.com/world-nation/story/2020-02-18/whitey-bulger-juror-say...

James “Whitey” Bulger terrorized Boston from the 1970s into the 1990s with a campaign of murder, extortion and drug trafficking. In 2013, Janet Uhlar was one of 12 jurors who found Bulger guilty in a massive racketeering case, including involvement in 11 murders. But now Uhlar says she regrets voting to convict Bulger on any of the murder charges. Her regret stems from a cache of more than 70 letters Bulger wrote to her from prison, some of which describe his unwitting participation in a secret CIA experiment with LSD. The agency dosed Bulger with the powerful hallucinogen more than 50 times when he was serving his first stretch in prison, in Atlanta. Uhlar has spoken publicly about her regret before but says her belief that the gangster was wrongly convicted on the murder charges was reinforced after reading a new book by Brown University professor Stephen Kinzer: “Poisoner in Chief: Sidney Gottlieb and the CIA Search for Mind Control.” Gottlieb’s secret program, known at MK-ULTRA, enlisted doctors and other subcontractors to administer LSD in large doses to prisoners, addicts and others unlikely to complain. Uhlar reviewed the 1977 hearings by the U.S. Senate Committee on Intelligence, which was looking into MK-ULTRA, and found testimony where CIA director Stansfield Turner acknowledged evidence showing that the agency had been searching for a drug that could prepare someone for “debilitating an individual or even killing another person.”

Note: Read more about the CIA's MK-ULTRA program. For more along these lines, see concise summaries of deeply revealing news articles on mind control from reliable major media sources.


Psychedelics: Can getting high improve your mental health?
2020-01-27, CNN News
https://www.cnn.com/2020/01/24/health/goop-psychedelics-wellness/index.html

Can the mind-blowing effects of psychedelics help heal our traumas? The scientific community [says] it's an increasingly hopeful thumbs up. Despite the fact that psychedelics are illegal, the last decade has seen an explosion of research, with results so intriguing that governments are greenlighting studies around the world. Scientists are busily exploring the role of hallucinogens on treatment-resistant depression, post traumatic stress disorder, cancer-related anxiety, addictions, and even anorexia. During the '40s and early '50s tens of thousands of patients took LSD and other psychotropics to study their effects on cancer anxiety, alcoholism, opioid use disorder, depression, and ... PTSD. Researchers began to see psychedelics as possible "new tools for shortening psychotherapy." In the 1950s UK psychiatrist Dr. Humphry Osmond began giving LSD to treatment-resistent alcoholics: 40% to 45% of those who took LSD were still sober after a year. [Then] in 1970, President Richard Nixon ... classified hallucinogenics as Schedule I drugs -- the most restrictive category. [Fast forward to today and] MAPS is in the final phase of a gold-standard study administering MDMA [Ecstasy] to 300 people with severe PTSD. Results of the second phase showed 68% of the people no longer met the criteria for PTSD at a 12-month follow-up; before the study they had suffered from treatment-resistant PTSD for an average of 17.8 years. The results are so positive that in January the FDA declared MDMA-assisted psychotherapy for PTSD a "Breakthrough Therapy." Perhaps one day soon a trip to the therapist will include a trip into your mind, and hopefully, a quicker path to healing.

Note: The full article at the link above gives a concise, yet thorough survey of the use of psychedelics for healing and growth over the years. For more along these lines, see concise summaries of deeply revealing news articles on the powerful healing potentials of some psychedelics from reliable major media sources.


Entrepreneurs At Davos This Week Portrayed Cannabis As A ‘Gateway’ Drug – But In A Good Way – For Mental Health Treatment
2020-01-23, Forbes
https://www.forbes.com/sites/joanoleck/2020/01/23/entrepreneurs-at-davos-this...

At this week’s World Economic Forum (WEF) in Davos, Switzerland, where the cannabis industry enjoyed a whole pavilion of its own, the biggest takeaway was where cannabis is headed in terms of human health. Rick Doblin, executive director of MAPS, the Multidisciplinary Association for Psychedelic Studies ... has delivered a TED talk on the future of psychedelic-assisted psychotherapy. And at Davos there was strong interest in the plant-based psychedelic molecules Doblin works with, [pharmacist Saul] Kaye said. “If you look at cannabis as an entryway into the market for botanical-based medicines, you can look at mushrooms, psilocybin,” said Kaye. “You can look at ibogaine, ayahuasca, which are new medicinal models that are breaking out in the world based on botanical medicine that has been illegal for the last 100 years. “Cannabis has elevated access to all kinds of botanical-based medicines, which ultimately can change mental health, physical health; and it’s a fascinating area that we can ... elevate the conversation around.” Other topics at the cannabis forum ... merited an “elevated” conversation of their own. A speaker from StemCell United, for example, addressed the fast expansion of CBD companies in Asia, building on what Kaye termed “a global de-stigmaization” across the Asian markets. The result, he said, has been to begin changing the traditional impression of cannabis from “This is illicit, this is a drug,” to, “This a research drug that is much safer than alcohol and tobacco.”

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psilocybin Sessions: Psychedelics could help people with addiction and anxiety
2019-12-29, CBS News
https://www.cbsnews.com/news/psychedelic-drugs-lsd-active-agent-in-magic-mush...

For most, psychedelic drugs conjure up images of the 1960's, hippies tripping out on LSD or magic mushrooms. But ... these powerful, mind-altering substances are now being studied seriously by scientists inside some of the country's foremost medical research centers. They're being used to treat depression, anxiety and addiction. The early results are impressive, as are the experiences of the studies' volunteers who go on a six-hour, sometimes terrifying, but often life-changing psychedelic journey. For nearly two decades now, [scientist Roland Griffiths] and his colleague Matthew Johnson have been giving what they call "heroic doses" of psilocybin to more than 350 volunteers, many struggling with addiction, depression and anxiety. Carine McLaughlin was a smoker for 46 years and said she tried everything to quit before being given psilocybin at Johns Hopkins last year. That was more than a year ago; she says she hasn't smoked since. The study she took part in is still ongoing, but in an earlier, small study of just 15 long-term smokers, 80% had quit six months after taking psilocybin. That's double the rate of any over-the-counter smoking cessation product. Jon Kostakopoulos was drinking a staggering 20 cocktails a night ... when he decided to enroll in another psilocybin trial at New York University. During one psilocybin session, he was flooded with powerful feelings and images from his past. He took psilocybin in 2016. He says he hasn't had a drink since.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Taking Ayahuasca When You’re a Senior Citizen
2019-10-17, New York Times
https://www.nytimes.com/2019/10/17/style/ayahuasca-senior-citizen.html

At 74, the venture capitalist George Sarlo might not have seemed an obvious candidate for an ayahuasca experience. Mr. Sarlo’s close friend, a doctor, told him about ayahuasca, a psychedelic brew made from the Banisteriopsis caapi vine, native to the Amazon. Used for centuries in sacred healing traditions throughout Central and South America, ayahuasca is now gaining popularity around the world. [It] is mostly illegal in the United States. Notably, ayahuasca’s increasing popularity knows no age limits: many of those now showing interest are squarely in Mr. Sarlo’s own demographic. Mr. Sarlo himself was initially skeptical. Taking ayahuasca would entail a potentially distressing night of hallucinations, and excretions of all kind, especially vomiting. But he still decided to head to Yelapa, a small village in Mexico, and swallow down the bitter brew. Mr. Sarlo said that afterward, something shifted. “It changed my life completely.” He realized that his life had been “absolutely full of miracles,” he said. As Michael Pollan put it, “psychedelics might be wasted on the young.” Mr. Pollan, the author of the recent best seller “How To Change Your Mind,” a history of psychedelics and a chronicle of his own experiences trying them, said ... he was surprised by the number of people he encountered when writing his book in their 70s and 80s expressing interest in trying psychedelics. Though perhaps he shouldn’t have been: as he himself has written, one of the reasons to come to psychedelics later in life is to tangle with one’s own mortality.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


The CIA's Secret Quest For Mind Control: Torture, LSD And A 'Poisoner In Chief'
2019-09-09, NPR
https://www.npr.org/2019/09/09/758989641/the-cias-secret-quest-for-mind-contr...

During the early period of the Cold War, the CIA became convinced that communists had discovered a drug or technique that would allow them to control human minds. In response, the CIA began its own secret program, called MK-ULTRA, to search for a mind control drug that could be weaponized against enemies. MK-ULTRA, which operated from the 1950s until the early '60s, was created and run by a chemist named Sidney Gottlieb. Some of Gottlieb's experiments were covertly funded at universities and research centers ... while others were conducted in American prisons and in detention centers in Japan, Germany and the Philippines. Many of his unwitting subjects endured psychological torture ranging from electroshock to high doses of LSD. In the early 1950s, he arranged for the CIA to pay $240,000 to buy the world's entire supply of LSD. He brought this to the United States, and he began spreading it around to hospitals, clinics, prisons and other institutions, asking them, through bogus foundations, to carry out research projects and find out what LSD was, how people reacted to it and how it might be able to be used as a tool for mind control. MK-ULTRA, was essentially a continuation of work that began in Japanese and Nazi concentration camps. Not only was it roughly based on those experiments, but the CIA actually hired the vivisectionists and the torturers who had worked in Japan and in Nazi concentration camps to come and explain what they had found out so that we could build on their research.

Note: Read more about the CIA's MK-ULTRA program. For more along these lines, see concise summaries of deeply revealing news articles on mind control from reliable major media sources.


Johns Hopkins Opens New Center for Psychedelic Research
2019-09-04, New York Times
https://www.nytimes.com/2019/09/04/science/psychedelic-drugs-hopkins-depressi...

Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, to study compounds like LSD and psilocybin for a range of mental health problems, including anorexia, addiction and depression. The center is the first of its kind in the country, established with $17 million in commitments from wealthy private donors and a foundation. The centers at Johns Hopkins and Imperial College give “psychedelic medicine,” as some call it, a long-sought foothold in the scientific establishment. Since the early 2000s, several scientists have been exploring the potential of psychedelics and other recreational drugs for psychiatric problems, and their early reports have been tantalizing. The emergence of depression treatment with the anesthetic and club drug ketamine and related compounds, which cause out-of-body sensations, also has piqued interest in mind-altering agents as aids to therapy. The ... funding will help clarify which drugs help which patients. Roland Griffiths, a neuroscientist at Johns Hopkins who will direct the new center ... said the new funds will cover six full-time faculty, five postdoctoral scientists and the costs of running trials. Among the first of those trials are a test of psilocybin for anorexia nervosa and of psilocybin for psychological distress and cognitive impairment in early Alzheimer’s disease. “The one that’s crying out to be done is for opiate-use disorder, and we also plan to look at that,” Dr. Griffiths said.

Note: Learn about the fascinating man who is bankrolling a significant portion of this new center in this New York Times article. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.